Healthcare -
Biotechnology - NASDAQ - US
$ 39.3
1.58 %
$ 11 B
Market Cap
22.33
P/E
EXEL - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity EXEL - Exelixis, Inc.
2.95 B
LAST VALUE
-2.04%
2 YEAR CAGR
9.35%
5 YEAR CAGR
24.56%
10 YEAR CAGR